SFL attends Swissmedic annual event

“Combination products: highly innovative, but complex”

Successful 4th Medtech & Pharma Platform 2017

Interview of SFL CEO Shayesteh Fürst-Ladani by Swiss Embassy

Meet us at the RAPS 2017 (Booth 604), 9-12 Sep 2017, Washington DC

CEO of SFL invited to speak about Strategies for Interacting With Global Regulatory Agencies at Biotech NetWorkshop in Munich, Germany

CEO of SFL invited to speak about European Orphan and Advanced Therapy Medicinal Products Regulations at GPKOL, South Korea

Shayesteh Fürst-Ladani, CEO of SFL, has been invited to give a key note speech at GPKOL (Global Pharma Key Opinion Leader) about European regulatory affairs with special focus on Orphan and Advanced Therapy Medicinal Products. GPKOL will take place during Bio Korea on 13 April 2017 in COEX Center in Seoul, South Korea. In her speech, Shayesteh will give an overview of the current as well as upcoming changes to both Regulations. Shayesteh will also attend Bio Korea and discuss opportunities for pharma and medtech companies interested in expansion from the Asia-Pacific region to Europe (EU and/or Switzerland).

Shayesteh has an extensive track record in negotiating company interests with different regulatory bodies and trade associations at a senior level. Her impressive contributions include organizing and chairing the RDAF (Rare Disease Action Forum) and international Medtech & Pharma Platform.

Please contact us to arrange a meeting with Shayesteh.

Shayesteh Fürst-Ladani, CEO of SFL, is attending the annual DIA Euromeeting taking place in Glasgow, Scotland

Shayesteh Fürst-Ladani, CEO of SFL, is attending the annual DIA Euromeeting taking place in Glasgow, Scotland, where she meets with top regulators and industry professionals in the development of drugs, devices and combination products. Shayesteh joins the entire conference from 29 to 31 March, representing SFL, a leading consultancy company providing integrated solutions in the areas of Regulatory Affairs, Quality Assurance, Public Affairs as well as Reimbursement and Medical Affairs.

Shayesteh Fürst-Ladani, CEO of SFL, is attending the upcoming BIO Asia in Tokyo, Japan, 14-15 March 2017

Shayesteh Fürst-Ladani, CEO of SFL, is attending the upcoming BIO Asia in Tokyo, Japan, 14-15 March 2017.  As a leading consultancy company providing integrated solutions in the areas of Regulatory Affairs, Medical Affairs, Public Affairs, Legal, Pharmacovigilance, Quality Assurance and Reimbursement, SFL is an ideal partner to support companies interested in bringing their products to the market or supporting due diligence negotiations both from the out-licensing and the in-licensing perspective.

Please contact us to arrange a meeting with Shayesteh.